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Central pontine myelinolysis (CPM) is a disease that may present with coma, quadriplegia, or no
symptoms at all. It is an iatrogenic demyelinating disease caused most frequently by overzealous
correction of chronic hyponatremia and excessive swings in serum osmolality. Lesions can also occur
outside the pons as extrapontine myelinolysis (EPM). Herein we have reported a case of CPM and EPM in
a patient after chemoradiotherapy for recurrent nasopharyngeal carcinoma.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Central pontine myelinolysis (CPM), ﬁrst described in 1959 by
Adam and associates, has been characterized primarily by the
symmetric, non-inﬂammatory destruction of myelin sheaths in the
basis pontis, and primarily results from aggressive correction of
hyponatremia.1 The label osmotic myelinolysis has been suggested
in preference to CPM due to the well-recognized occurrence of
extrapontine myelinolysis (CPM).2 CPM initially manifests with
dysarthria and dysphagia (corticobulbar tract involvement) before
progressing from ﬂaccid quadriparesis (corticospinal tract) to
spastic quadriparesis (basis pontis), and impaired consciousness.3
The traditionally proposed mechanism involves disruption of the
bloodebrain barrier with resultant vasogenic edema, ﬁber tract
compression, and myelinolysis. Some researchers hypothesized
that the pathological process started in the central pons due to its
region of maximal admixture of gray and white elements, and a
high concentration of oligodendrocytes.4,5 In a review by Stern and
colleagues, the rate of correction should not exceed 12 mEq/L
during the ﬁrst 24 h. However, CPM has also been described aslogy, Department of Internal
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CPM and EPM in a patient with recurrent nasopharyngeal carci-
noma with concurrent chemoradiotherapy.2. Case report
A 50-year-old female with a past medical history of hepatitis B
and Sicca syndrome presented with intermittent nasal bleeding
and was diagnosed approximately 2 years earlier with stage I
nasopharyngeal cancer (NPC) pT1N0M0. She underwent surgical
interventionwithin a month of the earlier diagnosis. One year later,
follow-up nasopharynx magnetic resonance imaging (MRI)
revealed suspicious tumor recurrence with lymphadenopathy over
the right level V. Lymph node biopsies were done twice and both
proved to be malignant, non-keratinizing carcinoma. She was
referred to our hospital outpatient department for further evalua-
tion and management. Upon physical examination, there was no
cranial nerve involvement, no bone pain nor tenderness, but an ill-
deﬁned, soft, non-tender and movable nodule over her right cer-
vical level V region was palpated. Lab data later revealed the pa-
tient's EBV viral load was 601 copies/mL (reference range <500
copies/mL). After ﬁberoptic examination of the nasopharynx was
performed, a largemass was discovered near Rosenmüller's fossa. A
subsequent whole body positron emission tomography (PET) scan
found areas with intensely increased FDG uptake in the naso-
pharynx, bilateral cervical lymph nodes of level V, left para-aorticElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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Nasopharynx magnetic resonance imaging (MRI) with contrast
revealed recurrent tumor in posterior-superior wall of right Rose-
nmüller's fossa, with extension through the right foramen lacerum
and left pterygopalatine fossa, without invasion of dural or brain
parenchyma or oropharynx. Besides, there were metastatic lymph
nodes in bilateral retropharyngeal spaces and right level II. Further
chest computed tomography (CT) showed a necrotic node in the
left suprahilar region, and tiny ground glass nodules in both lung
ﬁelds. Hence, she was admitted with a diagnosis of recurrent NPC
with suspected lung metastasis, non-keratinizing carcinoma,
rCT3N2M1, stage IV C.
A course of treatment was planned with TPF, followed by con-
current chemoradiotherapy (CCRT). The TPF regimen consisted of
docetaxel at a dose of 60 mg/m2, administered by a single 1-
h infusion on day 1, followed by Cisplatin at a dose of 80 mg/m2,
administered by a single 6-h infusion on day 1, and ﬂuorouracil at a
dose of 800 mg/m2 on continuous pump from day 1 to day 4. In-
duction chemotherapy was administered every 4 weeks for a total
of 4 courses. Hyponatremiawas ﬁrst encountered at the emergency
department after completion of the patients ﬁrst chemotherapy
regimen, with presentation of dizziness and irritation. Her serum
sodium level decreased from 137 mmol/L to 117 mmol/L in a week.
However, the clinical signs of volume depletion were not apparent,
and so the decrease was suspected to be due to chemotherapy.
Concurrent chemoradiotherapy was commenced following the
induction chemotherapy. External beam radiotherapy dose with
7000 cGy in 35 fractions to the nasopharyngeal and retro-
pharyngeal tumor, and 6000 cGy to the uninvolved lymphatic re-
gion were planned. She received 18 fractions (accumulated
treatment dose: 3600 cGy for nasopharynx and bilateral upper
neck; 3086 cGy for bilateral lower neck and basal skull margin) in
23 days for the ﬁrst time. Chemotherapy with PF was infused after
the 12th fraction of radiotherapy. Before chemotherapy, blood ex-
amination showed mild hyponatremia (serum sodium of
135 mmol/L, reference range 136e144 mmol/L) and mild hypoka-
lemia (serum potassium of 3.5 mmol/L, reference range
3.6e5.1 mmol/L). The PF regimen consisted of Cisplatin at a dose of
80 mg/m2, administered by a single 6-h infusion on day 1, and
Fluorouracil at a dose of 800 mg/m2 on continuous pump from day
1 to day 4. Acute radiation reactions with Grade 1 oropharyngeal
mucositis, and fatigue occurred after the 7th fraction of radio-
therapy. From thereon, symptomatic treatment for severe oral ul-
cers and odynophagia was provided.
One week after the CCRT, she was brought to our emergency
department due to fever, severe general weakness, and severe oral
pain. Her Sicca syndrome-related xerostomia had worsened due to
radiotherapy and was complicated with severe stomatitis, which
made oral intake difﬁcult. She took traditional Chinesemedicine for
symptomatic treatment. On physical examination, severe oral ul-
cers with crust, dry mucosa, decreased skin turgor, and no abnor-
mality of breath sound were found. On neurological examination,
there was no abnormality of mental status, cognition, cranial
nerves palsy, nor muscle power of the four limbs. The complete
blood count (CBC) included a white blood count of 300/mm3
(reference range 3500e9100/mm3) (58.0% neutrophils, 12.0% lym-
phocytes, 26.0%monocytes, and 2.0% eosinophils), hemoglobinwas
11.5 g/dL (reference range 12.0e15.0 g/dL), and platelet, 56000/
microL (reference range 157000e377000/microL). The level of so-
dium was 103 mmol/L (reference range 136e144 mmol/L), and
level of potassium, 2.2 mmol/L (reference range 3.6e5.1 mmol/L).
The levels of blood glucose, liver function test, renal function and
urinalysis were normal. Chest plain ﬁlm revealed no signiﬁcant
inﬁltration of lungs. Empirical antibiotic with piperacillin/tazo-
bactam 3375 mg every 6 h for neutropenic fever (ANC of 174 cells/micro L), 3% sodium chloride pump at the rate of 20 ml/h for severe
hyponatremia and 60 mEq potassium chloride were infused on the
ﬁrst day at the emergency department. Rapid rise of serum sodium
level from 103 mmol/L to 117 mmol/L in 12 h was noted by follow-
up biochemistry examination, so 3% sodium was discontinued and
0.9% sodium chloride was infused instead.
After admission to the ward, we continued the use of antibiotic
with piperacillin/tazobactam and added antifungal agent with
amphotericin B for neutropenic fever. We also administered
parenteral nutrition supplement and corrected severe multiple
electrolytes imbalance (hypokalemia, hypomagnesemia, hypocal-
cemia) (Fig. 2) over a period of time. No further fever was noted
after admission. However, symptoms such as slurred speech, limbs
weakness, and slow response were observed since the 3rd day of
admission. Drowsiness, tetraplegia, dysphagia, and dysarthria
became gradually obvious. Additionally, staring gaze, mutism,
stridor, locked-in syndrome like, intermittent muscle spasm over
limbs, spasticity of joints and foot drop developed as well.
Physical examination revealed GCS of E4V1M4, pupil size of
4 mm in both sides, and the presence of bilateral light reﬂex. She
could not obey visual acuity and visual ﬁeld examination, and her
extraocular muscles were at the neutral position. Muscle power of
all four limbs was 1 to pain and sensory deﬁcit was absent. Babinski
sign showed extensor plantar response in bilateral sides, and deep
tendon reﬂex was þ/þ. Brain CT revealed no intracranial hemor-
rhage. Lab examination showed level TSH and Free T4 were within
normal limit. The differential diagnoses were metabolic encepha-
lopathy possibly due to electrolyte imbalance like hyponatremia or
hypernatremia or chemotherapy, seizure which can be evoked by
hypocalcemia, hypomagnesemia, hyponatremia, hypernatremia),
CNS infection, or ischemic stroke.
Central pontine and extrapontine myelinolysis were diagnosed
by brain magnetic resonance imaging study (on the 12th day of
admission). There was symmetrically increased T2 weighted signal
intensity involving bilateral parietal cortex, basal ganglia, thalami,
and a star shape lesion in pons; they also showed water restriction
on diffusion weighted images (Fig. 1). Brain EEG showed near
continuous diffuse (wave at frequency of 5e7 Hz, and 30e45 UV in
amplitude) rhythmic theta activity alternating with suppressed
background.
We provided supportive care with physiotherapy, adequate
nutrition and electrolyte control, and infection control. Mild focal
seizure was noted about 1 month later and anti-epileptic agent was
prescribed. Her limb motor condition was gradually improved
during outpatient follow-up. Modiﬁed Ashworth scale was 2 in all
four limbs, and Brunnstrom's stage was III in left limbs and IV in
right limbs. With supportive care and intensive rehabilitation, her
dysphagia and extremity rigidity improved after two months. She
can walk with support and the NG tube was removed 6 months
later but still have rigidity of left upper extremity after the occur-
rence of CPM and EPM.
3. Discussion
A rapid correction of hyponatremia creates the hyperosmotic
stress that causes endothelial injury and then promotes opening of
the blood-brain barrier. This results in the direct release (from
endothelial injury) of myelinotoxic or oligodendroglial destructive
factors and blood derived myelinolytic factors. The central pons has
the greatest degree admixture of gray and white matter of all areas
of the brain, with the fact that graymatter contained 10-timesmore
capillaries than white matter which was enriched with myelin.
Hence, pons face is the greatest risk of demyelination.6 Unlike acute
hyponatremia in which osmotic equilibrium is restored following
rapid correction of hyponatremia, in chronic hyponatremia, cells
Fig. 1. T2 FLAIR (Left) and DWI (right) MRI: Symmetrically hyperintense signals on T2 FLAIR images within the central pons (A), basal ganglia (caudate, putamen, external capsule)
(C), thalami (C), and bilateral parietal cortices (E). They also showed water restriction on diffusion weighted images (B,D,F). The diagnosis of central pontine myelinolysis and
extrapontine myelinolysis in this patient was conﬁrmed by Brain MRI with contrast obtained after 12th day of admission.
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glutamate, creatinine, phosphocreatine, glycerophosphorylcho-
line), other than Naþ, Kþ, Cl ions. Following infusion of hypertonic
saline, ions reaccumalated into cells quickly but organic osmolytestake about 5 days to do so. High cerebral ion concentrationwith low
concentrations of organic osmolytes may have interfered normal
protein structure and function.6
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Fig. 2. Electrolytes changes throughout the hospital course of 40 days. Severe multiple electrolytes imbalances were observed in our patients before admission. Severe hypona-
tremia was corrected with 3% sodium chloride infusion initially. However, there was a serum sodium level overshoot from 103 mmol/L to 117 mmol/L in 12 h. The electrolyte
imbalances were corrected over a period of time.
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after rapid correction of hyponatremia. Predisposing factors to
development of ODS were syndrome of inappropriate antidiuretic
hormone, alcoholism, liver cirrhosis, liver transplantation, renal
failure, burns, malnutrition, or neoplasm. Other associated di-
agnoses include electrolyte imbalances (hypophosphatemia, hy-
pokalemia, and hyponatremia), renal failure, dialysis, hepatitis,
hyperemesis (hyperemesis gravidarum, anorexia nervosa or
bulimia, and pharmacologic side effects), diabetes mellitus, leuke-
mia, lymphoma, Wilson disease,7 sudden disruption of desmo-
pressin treatment in diabetes insipidus patient, and pituitary
surgery, a situation where SIADH may be a transient and resolved
suddenly.8 One research conducted in the intensive care unit found
that the most common associated factor was hypokalemia which is
deﬁned as serum potassium level of& 1.5 mEq/L (41%), followed by
chronic alcoholism, prolonged diuretic therapy, and postoperative
ﬂuid therapy (each about 30% of the cases).9
Our patient was admitted with mild dehydration and multiple
electrolyte disorders, especially severe hyponatremiamainly due tomalnutrition, resulting from preexisting xerostomia with severe
stomatitis after radiation therapy. This posed a serious threat to
various complications of electrolyte imbalances and risk of too
rapid correction of serum sodium level, consequently CPM devel-
oped in our patient. Other possible contributors of hyponatremia,
including syndrome of inappropriate antidiuretic hormone
(SIADH), secretion as paraneoplastic syndrome of nasopharyngeal
tumor or CCRT related SIADH should be ruled out. However, the
effort to properly diagnose SIADH requiring measurement of urine,
plasma osmolality and urine sodium at a minimum was lacking in
this case. The full diagnostic criteria should also include normal
thyroid and adrenal functions. There is one case report which is the
ﬁrst report of pathological conﬁrmation of the SIADH in nasopha-
ryngeal carcinoma bymolecular and immunologic studies. It shows
that ectopic secretion of vasopressin by the primary NPC tumor
appears to be the mechanism of paraneoplastic syndrome.10 One
author proposed that SIADH following chemoradiotherapy for
squamous cell carcinoma of head and neck might be produced by
the release of vasopressin after rapid tumor cells lysis due to
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ologic explanation, where six cases of SIADH received radical neck
dissection for cervical metastasis of head and neck cancer, with 5 of
them also receiving radiotherapy. They suggested that SIADH
resulted indirectly from increased intracranial pressure due to
impaired venous return.12 Our patient experienced hyponatremia
one week after her ﬁrst regimen of induction chemotherapy
without malnutrition status at that time. We highly suspect both
episodes of hyponatremia in this patient were possibly due to
SIADH following chemotherapy, although no laboratory support of
SIADH was made.
There are reports of therapeutic interventions to prevent ODS
after rapid correction of hyponatremia: reinduction of hypona-
tremia, administration of myo-inositol, urea, or minocycline (by
inhibiting the activation of microglia).13 Isolated case reports sug-
gest the role of steroids, plasmapharesis, and imidazolepyridine
tartrate in treatment of CPM.9 Aggresive supportive therapy should
be provided for managing complications of neurological deﬁcit
resulting from CPM.
Anyhow, prevention is better than cure. Verifying the chronicity
of hyponatremia (acute deﬁned as a duration of <48 h while
chronic deﬁned as a duration of 48 h) is much more crucial than
severity of hyponatremia before initiating sodium correction as to
avoid the rapidity of sodium rise which may end up with osmotic
demyelinating syndrome. Among the published recommendations,
there was no consensus about the optimal treatment for symp-
tomatic hyponatremia. However, blood sodium rise not exceeding
8e12 mmol/L/day is considered safe and widely accepted.14,15
Hence, frequent monitoring of serum sodium is needed to ensure
a graded correction of hyponatremia.
4. Conclusions
Our case suggested that CPM and EPM can also occur in cancer
patients with hyponatremia following CCRT, and illustrated the
importance of electrolyte monitoring and control. Therefore, thepossibility of developing CPM should be kept in mind when
providing medical care for such patients.Conﬂict of interest
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